Stenger Family Office’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$679K Buy
5,282
+286
+6% +$33.5K 0.11% 83
2026
Q1
$601K Sell
4,996
-23
-0.5% -$2.65K 0.11% 88
2025
Q4
$528K Sell
5,019
-7
-0.1% -$657 0.11% 79
2025
Q3
$442K Sell
5,026
-43,652
-90% -$3.6M 0.09% 86
2025
Q2
$3.98M Buy
+48,678
New +$3.87M 1.02% 25
2024
Q4
$298K Buy
+2,999
New +$309K 0.1% 83

Other funds holding MRK

Stenger Family Office's MRK Position: Q2 2026 in Review

Stenger Family Office increased its Merck (MRK) stake by 5.7% in Q2 2026, buying an estimated $33.5K and bringing the position to 5,282 shares worth $679K. The position accounts for 0.11% of the portfolio, ranked #83.

Stenger Family Office first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.98M in Q2 2025. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Stenger Family Office held 5,282 shares of Merck worth $679K as of Q2 2026.
  • Stenger Family Office bought 286 Merck shares in Q2 2026, an estimated $33.5K.
  • Merck made up 0.11% of Stenger Family Office's portfolio in Q2 2026, its #83 holding.
  • Stenger Family Office first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
  • Stenger Family Office's Merck position peaked at $3.98M in Q2 2025.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Stenger Family Office's 13F filing for Q2 2026, filed 13 Jul 2026.